Adult Sarcoma

Friday, May 4, 2018 from 8:30 AM to 9:15 AM
Available for up to 0.75 hours of CPE credit
Activity Number: 0217-9999-18-081-L01-P

Sara K. Butler, Pharm.D., BCPS, BCOP

  • Faculty: Sara K. Butler, Pharm.D., BCPS, BCOP
    Clinical Pharmacy Specialist, Medical Oncology Clinical Oncology Supervisor PGY-2 Oncology Residency Program Director Barnes-Jewish Hospital St. Louis, Missouri
      View Biography

Learning Objectives
1. Design an appropriate patient-specific treatment, management, and monitoring plan taking into consideration efficacy and safety outcomes from clinical trials and current treatment guidelines for adult patients with sarcoma.
2. Adjust treatment and monitoring plans as needed based on the pharmacokinetics of anticancer and supportive-care agents (e.g., methotrexate).
3. Devise and communicate appropriate plans for preventing, monitoring, and managing common problems associated with the treatment of adult patients with cancer including neurotoxicity from ifosfamide and hemorrhagic cystitis.
© 2019 American College of Clinical Pharmacy and American Society of Health‑System Pharmacists